Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

OSL:BNOR - Euronext Oslo - NO0010379266 - Common Stock - Currency: NOK

640  +17 (+2.73%)

Fundamental Rating

3

Overall BNOR gets a fundamental rating of 3 out of 10. We evaluated BNOR against 61 industry peers in the Oil, Gas & Consumable Fuels industry. BNOR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BNOR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BNOR has reported negative net income.
In the past year BNOR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BNOR reported negative net income in multiple years.
BNOR had a positive operating cash flow in each of the past 5 years.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BNOR has a worse Return On Assets (-1.36%) than 85.25% of its industry peers.
BNOR's Return On Equity of -6.44% is on the low side compared to the rest of the industry. BNOR is outperformed by 88.52% of its industry peers.
BNOR has a worse Return On Invested Capital (5.00%) than 70.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BNOR is significantly below the industry average of 14.55%.
The 3 year average ROIC (9.38%) for BNOR is well above the current ROIC(5.00%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.36%
ROE -6.44%
ROIC 5%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

With a decent Operating Margin value of 27.70%, BNOR is doing good in the industry, outperforming 63.93% of the companies in the same industry.
In the last couple of years the Operating Margin of BNOR has grown nicely.
Looking at the Gross Margin, with a value of 55.08%, BNOR is in the better half of the industry, outperforming 62.30% of the companies in the same industry.
BNOR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.7%
PM (TTM) N/A
GM 55.08%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BNOR is creating some value.
BNOR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BNOR has been increased compared to 5 years ago.
Compared to 1 year ago, BNOR has a worse debt to assets ratio.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of BNOR is 13.72, which is on the high side as it means it would take BNOR, 13.72 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.72, BNOR is doing worse than 63.93% of the companies in the same industry.
A Debt/Equity ratio of 1.53 is on the high side and indicates that BNOR has dependencies on debt financing.
The Debt to Equity ratio of BNOR (1.53) is worse than 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 13.72
Altman-Z N/A
ROIC/WACC0.59
WACC8.43%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

BNOR has a Current Ratio of 1.20. This is a normal value and indicates that BNOR is financially healthy and should not expect problems in meeting its short term obligations.
BNOR has a worse Current ratio (1.20) than 68.85% of its industry peers.
A Quick Ratio of 1.07 indicates that BNOR should not have too much problems paying its short term obligations.
BNOR's Quick ratio of 1.07 is in line compared to the rest of the industry. BNOR outperforms 44.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.07
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The earnings per share for BNOR have decreased strongly by -298.18% in the last year.
The Revenue has decreased by -5.10% in the past year.
Measured over the past years, BNOR shows a quite strong growth in Revenue. The Revenue has been growing by 16.10% on average per year.
EPS 1Y (TTM)-298.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)-5.1%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%1.54%

3.2 Future

Based on estimates for the next years, BNOR will show a very strong growth in Earnings Per Share. The EPS will grow by 30.91% on average per year.
BNOR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.69% yearly.
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5Y30.91%
Revenue Next Year80.41%
Revenue Next 2Y35.27%
Revenue Next 3Y20.1%
Revenue Next 5Y8.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -100 -200 -300

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNOR. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.68 indicates a rather cheap valuation of BNOR.
Based on the Price/Forward Earnings ratio, BNOR is valued a bit cheaper than the industry average as 78.69% of the companies are valued more expensively.
BNOR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 7.68
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

67.21% of the companies in the same industry are cheaper than BNOR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as BNOR.
Industry RankSector Rank
P/FCF 17.02
EV/EBITDA 7.58
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BNOR's earnings are expected to grow with 68.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.96%
EPS Next 3Y68.13%

0

5. Dividend

5.1 Amount

BNOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (6/19/2025, 7:00:00 PM)

640

+17 (+2.73%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)07-10 2025-07-10
Inst Owners33.4%
Inst Owner ChangeN/A
Ins Owners1.13%
Ins Owner ChangeN/A
Market Cap16.96B
Analysts82.86
Price Target738.82 (15.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-243.6%
Min EPS beat(2)-415.9%
Max EPS beat(2)-71.31%
EPS beat(4)0
Avg EPS beat(4)-163.08%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)1
Avg EPS beat(8)-100.79%
EPS beat(12)3
Avg EPS beat(12)-92.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.2%
Min Revenue beat(2)-33.43%
Max Revenue beat(2)-8.97%
Revenue beat(4)1
Avg Revenue beat(4)-12.39%
Min Revenue beat(4)-33.43%
Max Revenue beat(4)4.82%
Revenue beat(8)3
Avg Revenue beat(8)-4.3%
Revenue beat(12)5
Avg Revenue beat(12)-2.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.01%
PT rev (3m)-5.19%
EPS NQ rev (1m)-5.01%
EPS NQ rev (3m)-8.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.27%
Revenue NQ rev (1m)-9%
Revenue NQ rev (3m)-10.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.68
P/S 2.42
P/FCF 17.02
P/OCF 5.95
P/B 2.31
P/tB 2.86
EV/EBITDA 7.58
EPS(TTM)-21.68
EYN/A
EPS(NY)83.37
Fwd EY13.03%
FCF(TTM)37.6
FCFY5.87%
OCF(TTM)107.51
OCFY16.8%
SpS264.55
BVpS277.23
TBVpS223.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE -6.44%
ROCE 6.5%
ROIC 5%
ROICexc 5.8%
ROICexgc 6.14%
OM 27.7%
PM (TTM) N/A
GM 55.08%
FCFM 14.21%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 13.72
Debt/EBITDA 3.28
Cap/Depr 123.87%
Cap/Sales 26.43%
Interest Coverage 1.4
Cash Conversion 82.88%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.07
Altman-Z N/A
F-Score3
WACC8.43%
ROIC/WACC0.59
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5Y30.91%
Revenue 1Y (TTM)-5.1%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%1.54%
Revenue Next Year80.41%
Revenue Next 2Y35.27%
Revenue Next 3Y20.1%
Revenue Next 5Y8.69%
EBIT growth 1Y-30.7%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year255.42%
EBIT Next 3Y53.78%
EBIT Next 5Y23.2%
FCF growth 1Y-73.6%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y-54.57%
OCF growth 3Y84.65%
OCF growth 5Y4.46%